Dynavax Technologies Stock Investor Sentiment

DVAX Stock  USD 13.62  0.02  0.15%   
Slightly above 54% of Dynavax Technologies' investor base is interested to short. The analysis of the overall investor sentiment regarding Dynavax Technologies suggests that many traders are impartial. Dynavax Technologies' investing sentiment can be driven by a variety of factors including economic data, Dynavax Technologies' earnings reports, geopolitical events, and overall market trends.

Comfort Level 46

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Dynavax Technologies' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Dynavax Technologies.

Dynavax Historical Sentiment

Although Dynavax Technologies' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Dynavax, such as negative comments on social media and news outlets, may cause fear in the market and push Dynavax Technologies' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Dynavax.
  

Dynavax Technologies Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Dynavax Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Dynavax Technologies Historical Investor Sentiment

Investor biases related to Dynavax Technologies' public news can be used to forecast risks associated with an investment in Dynavax. The trend in average sentiment can be used to explain how an investor holding Dynavax can time the market purely based on public headlines and social activities around Dynavax Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dynavax Technologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dynavax Technologies and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Dynavax Technologies news discussions. The higher the estimate score, the more favorable the investor's outlook on Dynavax Technologies.
17 hours ago at zacks.com         
Why Dynavax Technologies Stock Might be a Great Pick
zacks News
a day ago at finance.yahoo.com         
JNJs Nipocalimab Gets FDAs Fast Track Tag for Sjogrens Disease
Yahoo News
2 days ago at www.macroaxis.com         
Disposition of 14020 shares by David Novack of Dynavax Technologies at 13.58 subject to Rule 16b-3
Macroaxis News
3 days ago at finance.yahoo.com         
AZNs Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer
Yahoo News
3 days ago at zacks.com         
AZNs Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer
zacks News
six days ago at finance.yahoo.com         
AMRNs Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
Yahoo News
over a week ago at zacks.com         
Wall Street Analysts See an 83.1 percent Upside in Dynavax Technologies Can the Stock Really Move Th...
zacks News
over a week ago at finance.yahoo.com         
Wall Street Analysts See an 83.1 percent Upside in Dynavax Technologies Can the Stock Really Move Th...
Yahoo News
over a week ago at finance.yahoo.com         
Deep Track Capital Sends Letter to Dynavax Technologies Board of Directors
Yahoo News
over a week ago at www.macroaxis.com         
Disposition of 32764 shares by David Novack of Dynavax Technologies at 14. subject to Rule 16b-3
Macroaxis News
over a week ago at finance.yahoo.com         
Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
Yahoo News
over a week ago at seekingalpha.com         
Dynavax to execute debt refinancing
seekingalpha News
over a week ago at gurufocus.com         
Dynavax Technologies Corp Announces Convertible Debt Refinancing and Stock Repurchase
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Has ANI Pharmaceuticals Outpaced Other Medical Stocks This Year?
Yahoo News
over two weeks ago at zacks.com         
Has ANI Pharmaceuticals Outpaced Other Medical Stocks This Year?
zacks News
Far too much social signal, news, headlines, and media speculation about Dynavax Technologies that are available to investors today. That information is available publicly through Dynavax media outlets and privately through word of mouth or via Dynavax internal channels. However, regardless of the origin, that massive amount of Dynavax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Dynavax Technologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Dynavax Technologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Dynavax Technologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Dynavax Technologies alpha.

Dynavax Technologies Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Dynavax Technologies Modifies Rights Agreement in Recent 8-K Filing
12/30/2024
2
Dynavax Technologies Shows Rising Relative Strength Still Shy Of Key Threshold
02/03/2025
3
Disposition of 6666 shares by Justin Burgess of Dynavax Technologies subject to Rule 16b-3
02/10/2025
4
Disposition of 11209 shares by Ryan Spencer of Dynavax Technologies at 13.2 subject to Rule 16b-3
02/12/2025
5
Disposition of 13000 shares by Robert Janssen of Dynavax Technologies subject to Rule 16b-3
02/13/2025
6
Disposition of 22620 shares by David Novack of Dynavax Technologies subject to Rule 16b-3
02/18/2025
7
Dynavax Technologies Corp Q4 2024 Earnings EPS Surpasses Estimates at 0. ...
02/20/2025
8
Q4 2024 Dynavax Technologies Corp Earnings Call Transcript
02/21/2025
9
Wall Street Analysts Think Dynavax Technologies Could Surge 81.92 percent Read This Before Placing a Bet
02/24/2025
10
Dynavax to Participate in Upcoming Investor Conferences
02/25/2025
11
Has ANI Pharmaceuticals Outpaced Other Medical Stocks This Year
03/05/2025
12
Dynavax Technologies Corp Announces Convertible Debt Refinancing and Stock Repurchase
03/06/2025
13
Disposition of 32764 shares by David Novack of Dynavax Technologies at 14. subject to Rule 16b-3
03/07/2025
14
Deep Track Capital Sends Letter to Dynavax Technologies Board of Directors
03/10/2025
15
AMRNs Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan
03/13/2025
16
Disposition of 14020 shares by David Novack of Dynavax Technologies at 13.58 subject to Rule 16b-3
03/18/2025
17
JNJs Nipocalimab Gets FDAs Fast Track Tag for Sjogrens Disease
03/19/2025

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.